Non-Animal Alternatives Testing Market: A Comprehensive Study - Global Forecast 2024

The non-animal alternatives testing market size has grown rapidly in recent years. It will grow from $2.08 billion in 2023 to $2.33 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to strong economic growth in emerging markets, the high costs of animal studies, the increasing adoption of in-vitro and in-silico technologies in basic research, the rising investments and the rise in research grants for developing alternative technologies and the increasing social awareness against animal cruelty..

The non-animal alternatives testing market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to government programs for non-animal alternative testing, the rise in the number of research and development activities and ethical concerns on animal experimentations will drive the growth.. Major trends in the forecast period include focus on advancing ooc technology, focus on use of in silico trials, developing advanced 3d bio-printed organs and tissues, use of model organisms, collaborations and partnerships, and rising initiatives and grants to promote animal-free testing..

Market Overview -
The non-animal alternatives testing is testing products and services that do not involve testing on animals to determine the safety and efficacy of products and ingredients used in any industry sector. Non-animal alternative testing technologies include: in-vitro human cell and tissue cultures; organs-on-chips (OOCs); computer simulations and modelling (silico models); 3D bio-printing of tissues; and synthetic skin substitutes; as well as studies with human volunteers. These technologies replace animal testing in end-use industries including pharmaceuticals, medical devices, chemicals and pesticides, food, and others.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2819&type=smp

Government And Non-Governmental Support Catalysts For Non-Animal Testing Market Growth
The support from the government and non-governmental organizations boosts the growth of the non-animal testing market. The government organizations enforce laws and regulations, raise funds to support non-animal testing methods such as tests on human volunteers, and advanced computer-modeling techniques, and also fund studies with human volunteers. In order to support non-animal testing, People for the Ethical Treatment of Animals (PETA) India, in 2022, announced a grant of 7 lakh rupees in order to advance animal-free methods for toxicology testing. Similar research programs to promote non-animal testing procedures are also initiated by countries such as Denmark, Brazil, Germany, Switzerland, Australia, China, and Korea. The constant support from the government drives the growth of the non-animal testing market.

Competitive Landscape -
Major companies operating in the non-animal alternatives testing market report are Evotec SE (Cyprotex), Bio-Rad Laboratories, Inc, BioIVT, Emulate, Inc, MatTek Corporation, SGS SA, Gentronix Limited, Promega Corporation, InSphero, VITROCELL Systems GmbH, Abbott India Limited, Becton Dickinson Private Limited, Biocartis Group NV, Bio-Techne India Private Limited, Danaher, Cleaver Scientific, China Tissue Engineering Co., Ltd. (J-TEC), Reprocell, Inc., Organ Technologies Co. Ltd, Mimetas, JRF Global, PharmaCo-Cell Company Ltd, Vessel Inc, Modulus Discovery, Sanofi, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Qiagen N.V, bioMérieux SA, QuantuMDx, Interlabservis, Roche Diagnostics, GeneMe, TestLine Clinical Diagnostics s.r.o, Thermo Fisher Scientific, PerkinElmer, GE Healthcare, Waters Corporation, Agilent Technologies, Bruker Corporation, Oxford Nanopore Technologies, 10x Genomics, Organovo Holdings, EMD Millipore, Cyprotex, RegeneMed Inc, HµREL Corporation, Nortis, In Silico Biosciences Inc, IOMICS Corporation, Charles River Laboratories, The Jackson Laboratory, Envigo, Taconic Biosciences, Inc., Cyagen Biosciences, Crown Biosciences, Harbour BioMed, Genewiz, Pacific Biosciences, Group 42 (G42) Healthcare, I-ONE, Wadi Jeddah Co, Philips, King Abdullah International Medical Research Center, Parexel, Soins Global, Pfizer South Africa, Dischem Pharmacy, Cipla Medpro South Africa Limited, Novartis South Africa, Synexa Life Sciences, IQVIA, Oceanic S. A, Hean

Fostering Progress Through Collaboration With Major Companies Join Forces For Animal-Free Testing Advancements
Major Companies operating in non-animal alternative testing are collaborating to alternatives to animal testing to gain a competitive edge in the market. The company's collaboration accelerates the use of animal-free safety science. For instance, in February 2023, Unilever, a UK-based company that manufactures healthcare products collaborated with global partnership of cosmetics manufacturers and suppliers, industry associations and animal protection organizations. This partnership aims to support innovation in animal-free cosmetics and personal care products and ingredients by funding and, scientific evaluation of new safety assessment approaches to help build confidence in animal-free safety science.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/non-animal-alternatives-testing-global-market-report

Key Segments -
The non-animal alternatives testing market covered in this report is segmented -
1) By Technology: Cell Culture Technology, High Throughput Technology, Molecular Imaging, Omics Technology, Other Technologies
2) By Method: Cellular Assay, Biochemical Assay, In Silico, Ex-Vivo
3) By End-User: Pharmaceutical Industry, Cosmetics And Household Products, Diagnostics, Chemicals Industry, Food And Beverage Industry, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.